Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | valine | 83769 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 88039 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
GC POSITIVE ION MODE | valine | 114076 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 123050 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 128288 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 137682 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | valine | 147100 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | valine | 147960 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | valine | 156392 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 175018 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | valine | 180805 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 188184 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 197182 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | valine | 215054 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 219060 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | valine | 229529 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 246580 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | valine | 247567 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | valine | 250982 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | valine | 269339 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | valine | 270684 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 283491 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | valine | 293247 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 303947 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 305952 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 306491 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | valine | 307998 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 310366 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 337206 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 339671 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 353289 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | valine | 354097 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 359051 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | valine | 362478 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | valine | 377563 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 379326 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 382474 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 383995 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 390402 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 399427 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 426388 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | valine | 441539 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | valine | 444073 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | valine | 445323 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | valine | 486300 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 488149 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 509936 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 515002 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 521217 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 524577 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 548523 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | valine | 576778 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 654216 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | valine | 685548 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | valine | 719801 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | valine | 740363 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | valine | 920512 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | valine | 1066572 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |